Overview

Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.

Status:
Terminated
Trial end date:
2015-07-30
Target enrollment:
Participant gender:
Summary
The study will be an adaptive, 2 part, single dose, 5-way crossover gamma scintigraphy study in healthy subjects, to investigate the rate and site of tablet disintegration of various forms of Ibuprofen.
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser Healthcare (UK) Limited
Treatments:
Ibuprofen